PACLITAXEL Side Effects

7019513-1 | Bronchospasm, Chest Discomfort, Flushing, Hypersensitivity, Infusion Related Reaction
on Jul 06, 2009 Female patient from NORWAY , 62 years of age, was diagnosed with ovarian cancer and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: bronchospasm, chest discomfort, flushing, hypersensitivity, infusion related reaction. Paclitaxel dosage: .

7019279-5 | Activated Partial Thromboplastin Time Prolonged, Blood Fibrinogen Increased, Haematuria, Haemophilia A With Anti Factor Viii, White Blood Cell Count Increased
Patient was taking Paclitaxel (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, blood fibrinogen increased, haematuria, haemophilia a with anti factor viii, white blood cell count increased on Sep 08, 2010 from UNITED STATES Additional patient health information: Female patient , 76 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Paclitaxel dosage: . During the same period patient was treated with TRASTUZUMAB (TRASTUZUMAB) (View Trastuzumab (trastuzumab) Review and Trastuzumab (trastuzumab) Label ), ATORVASTATIN (ATORVASTATIN) (View Atorvastatin (atorvastatin) Review and Atorvastatin (atorvastatin) Label ). Patient was hospitalized.

7014805-4 | Blood Creatinine Increased, Hypertension, Oedema Peripheral, Proteinuria
Adverse event was reported on Sep 24, 2010 by a Female patient taking Paclitaxel (View Usage) (Dosage: ) was diagnosed with breast cancer metastatic and. Location: GREECE , 74 years of age, After Paclitaxel was administered, patient had the following side effects: blood creatinine increased, hypertension, oedema peripheral, proteinuria. During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

7014348-8 | Neuropathy Peripheral
on Sep 24, 2010 Female patient from UNITED STATES , 64 years of age, was diagnosed with endometrial cancer and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: neuropathy peripheral. Paclitaxel dosage: 175mg/m2 Q3weeks Iv, 6 Weeks -2 Cycles-.


7014338-5 | Neuropathy Peripheral
on Sep 24, 2010 Female patient from UNITED STATES , 69 years of age, was diagnosed with non-small cell lung cancer and was treated with Paclitaxel (View Usage). Patient had the following side effects: neuropathy peripheral. Paclitaxel dosage: 200mg/me Q3weeks Iv, 3 Weeks, 1 Cycle.

7009275-6 | Hyponatraemia, Neutropenia, Oesophagitis, Thrombocytopenia
Patient was taking Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: hyponatraemia, neutropenia, oesophagitis, thrombocytopenia on Sep 14, 2010 from UNITED STATES Additional patient health information: Female patient , 62 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and. Paclitaxel dosage: Discontinued On 27aug10. During the same period patient was treated with CARBOPLATIN (1df= 6 Auc; Taken Off The Protocol On 27aug10) (View Carboplatin Review and Carboplatin Label ), BEVACIZUMAB (Taken Off The Protocol On 27aug10) (View Bevacizumab Review and Bevacizumab Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LASIX (View Lasix Review and Lasix Label ), REGLAN (View Reglan Review and Reglan Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), COMPAZINE (View Compazine Review and Compazine Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ). Patient was hospitalized.

7006578-6 | Hyperhidrosis, Pallor, Syncope, Unresponsive To Stimuli
Adverse event was reported on Sep 21, 2010 by a Male patient taking Paclitaxel (View Usage) (Dosage: 88mg Qweek Iv) was diagnosed with malignant pleural effusion and. Location: UNITED STATES , 80 years of age, weighting 156.5 lb, Patient experienced the following unwanted or unexpected effects: hyperhidrosis, pallor, syncope, unresponsive to stimuli. During the same period patient was treated with CARBOPLATIN (158mg Qweek Iv) (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6992230-X | Hyponatraemia, Neutropenia, Oesophagitis, Thrombocytopenia
on Sep 14, 2010 Female patient from UNITED STATES , 62 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer and was treated with Paclitaxel (View Usage). Patient had the following side effects: hyponatraemia, neutropenia, oesophagitis, thrombocytopenia. Paclitaxel dosage: Discontinued On 27aug10. During the same period patient was treated with CARBOPLATIN (1df= 6 Auc; Taken Off The Protocol On 27aug10) (View Carboplatin Review and Carboplatin Label ), BEVACIZUMAB (Taken Off The Protocol On 27aug10) (View Bevacizumab Review and Bevacizumab Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LASIX (View Lasix Review and Lasix Label ), REGLAN (View Reglan Review and Reglan Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), COMPAZINE (View Compazine Review and Compazine Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ). Patient was hospitalized.

6979515-8 | Dyspnoea
on Sep 06, 2010 Female patient from INDIA , weighting 116.8 lb, was diagnosed with breast cancer (What is breast cancer?), hypothyroidism and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: dyspnoea. Paclitaxel dosage: 80 Mg/m2 On Days 1, 8, And 15 Of 4 Week. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ). Patient was hospitalized.

6971974-X | Hypersensitivity, Paraesthesia, Scleroderma
Patient was taking Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: hypersensitivity, paraesthesia, scleroderma (What is scleroderma?) on Aug 24, 2010 from DENMARK Additional patient health information: Female patient , 52 years of age, was diagnosed with ovarian cancer, malignant peritoneal neoplasm, hypersensitivity, anaesthesia and. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (Auc Of 5) (View Carboplatin Review and Carboplatin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), PROPOFOL (View Propofol Review and Propofol Label ).

6971194-9 | Hypersensitivity, Paraesthesia, Scleroderma
Adverse event was reported on Aug 24, 2010 by a Female patient taking Paclitaxel (View Usage) (Dosage: ) was diagnosed with ovarian cancer, malignant peritoneal neoplasm, hypersensitivity, anaesthesia and. Location: DENMARK , 52 years of age, Patient had the following side effects: hypersensitivity, paraesthesia, scleroderma (What is scleroderma?). During the same period patient was treated with CARBOPLATIN (Auc Of 5) (View Carboplatin Review and Carboplatin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), PROPOFOL (View Propofol Review and Propofol Label ).

6969045-1 | Hypersensitivity, Paraesthesia, Scleroderma
on Aug 24, 2010 Female patient from DENMARK , 52 years of age, was diagnosed with ovarian cancer, malignant peritoneal neoplasm, hypersensitivity, anaesthesia and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: hypersensitivity, paraesthesia, scleroderma (What is scleroderma?). Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (Auc Of 5) (View Carboplatin Review and Carboplatin Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), PROPOFOL (View Propofol Review and Propofol Label ).

6966441-3 | Caesarean Section, Normal Newborn, Pregnancy
on Aug 30, 2010 Female patient from JAPAN , 27 years of age, was diagnosed with cervix carcinoma and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, normal newborn, pregnancy (What is pregnancy?). Paclitaxel dosage: 30 + 4 Weeks Of Gestation. During the same period patient was treated with CISPLATIN (33 + 4 Weeks Gestation) (View Cisplatin Review and Cisplatin Label ).

6966439-5 | Caesarean Section, Normal Newborn, Pregnancy
Patient was taking Paclitaxel (View Usage). Patient had the following side effects: caesarean section, normal newborn, pregnancy (What is pregnancy?) on Aug 30, 2010 from JAPAN Additional patient health information: Female patient , 32 years of age, was diagnosed with squamous cell carcinoma and. Paclitaxel dosage: 29 + 2 Weeks Of Gestation. During the same period patient was treated with CARBOPLATIN (1 Df= Auc 5 29 + 2 Weeks Of Gestation) (View Carboplatin Review and Carboplatin Label ).

6966437-1 | Caesarean Section, Mass, Normal Newborn, Pregnancy, Spinal Cord Compression
Adverse event was reported on Aug 30, 2010 by a Female patient taking Paclitaxel (View Usage) (Dosage: At 26, 29 And 32 Weeks Gestation) was diagnosed with cervix carcinoma and. Location: JAPAN , 27 years of age, After Paclitaxel was administered, patient had the following side effects: caesarean section, mass, normal newborn, pregnancy (What is pregnancy?), spinal cord compression. During the same period patient was treated with CISPLATIN (At 26, 29 And 32 Weeks Gestation) (View Cisplatin Review and Cisplatin Label ).

6966426-7 | Scleroderma
on Aug 31, 2010 Female patient from JAPAN , 67 years of age, was diagnosed with ovarian cancer and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: scleroderma (What is scleroderma?). Paclitaxel dosage: 1df: 175mg/m Sup(2)(90% Of Paclitaxel = 210 Mg/body)5th Course Withdrawn. During the same period patient was treated with CARBOPLATIN (1df: 500mg/body,auc 5 Also Recieves On 20-nov-2007,600mg/body.5th Course Withdrawn) (View Carboplatin Review and Carboplatin Label ).

6962745-9 | Hypersensitivity, Oedema, Paraesthesia, Raynaud's Phenomenon, Scleroderma
on Aug 26, 2010 Female patient from DENMARK , 52 years of age, was diagnosed with ovarian cancer and was treated with Paclitaxel (View Usage). Patient had the following side effects: hypersensitivity, oedema, paraesthesia, raynaud's phenomenon, scleroderma (What is scleroderma?). Paclitaxel dosage: 175 Mg/m2;dose Reduced To 25% In 7th Cycle;taken 8 Cycles;. During the same period patient was treated with CARBOPLATIN (Auc 5.) (View Carboplatin Review and Carboplatin Label ).

6958051-9 | Panic Attack
Patient was taking Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: panic attack on Aug 26, 2010 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 121.3 lb, was diagnosed with metastatic malignant melanoma and. Paclitaxel dosage: On Day 1,8 And 15 Every 28 Days.. Patient was hospitalized.

6957778-2 | Anaphylactic Reaction, Cardio-respiratory Arrest, Respiratory Depression
Adverse event was reported on Aug 30, 2010 by a Male patient taking Paclitaxel (View Usage) (Dosage: 50 Mg Once Iv) was diagnosed with lung neoplasm malignant and. Location: UNITED STATES , 40 years of age, weighting 134.5 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic reaction, cardio-respiratory arrest, respiratory depression. Patient was hospitalized.

6956030-9 | Dyspnoea, Loss Of Consciousness
on Aug 19, 2010 Male patient from UNITED KINGDOM , 55 years of age, was treated with Paclitaxel (View Usage). Patient had the following side effects: dyspnoea, loss of consciousness. Paclitaxel dosage: 160 Mg Milligram(a) Intravenous. During the same period patient was treated with (BEVACIZUMAB) (View (bevacizumab) Review and (bevacizumab) Label ), (CHLORPHENAMINE) (View (chlorphenamine) Review and (chlorphenamine) Label ), (DEXAMETASONE) (View (dexametasone) Review and (dexametasone) Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

6945672-2 | Arthralgia, Dyspnoea, Fibrosis, Microstomia, Motor Dysfunction, Oedema, Paraesthesia, Raynaud's Phenomenon, Scleroderma
on Aug 19, 2010 Female patient from DENMARK , 52 years of age, was diagnosed with ovarian cancer, anaesthesia and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: arthralgia, dyspnoea, fibrosis, microstomia, motor dysfunction, oedema, paraesthesia, raynaud's phenomenon, scleroderma (What is scleroderma?). Paclitaxel dosage: 305 Mg (175 Mg/m^2), Qw3. During the same period patient was treated with CARBOPLATIN (525 Mg, Unk) (View Carboplatin Review and Carboplatin Label ), FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), PROPOFOL (View Propofol Review and Propofol Label ), ALFENTANIL (View Alfentanil Review and Alfentanil Label ).

6943437-9 | Flushing, Hypertension, Loss Of Consciousness
Patient was taking Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: flushing, hypertension, loss of consciousness on Aug 12, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 51 years of age, weighting 165.3 lb, was diagnosed with breast cancer recurrent and. Paclitaxel dosage: 162 Mg Milligram(s), 1 Week, Intravenous. During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), (CLEXANE) (View (clexane) Review and (clexane) Label ).

6943436-7 | Loss Of Consciousness
Adverse event was reported on Aug 12, 2010 by a Female patient taking Paclitaxel (View Usage) (Dosage: 62 Mg Cyclic, Intravenous) . Location: ITALY , 86 years of age, Patient had the following side effects: loss of consciousness. Patient was hospitalized.

6942345-7 | Failure To Thrive, Lung Disorder, Malignant Neoplasm Progression, Pneumothorax
on Aug 23, 2010 Male patient from UNITED STATES , 64 years of age, weighting 112.4 lb, was diagnosed with non-small cell lung cancer, insomnia, constipation (What is constipation?), hypercholesterolaemia, dyspnoea, cough, pain (What is pain?) and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: failure to thrive, lung disorder, malignant neoplasm progression, pneumothorax. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), DOCUSATE SODIUM (1 Df - 100-200mg) (View Docusate Sodium Review and Docusate Sodium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ALBUTEROL SULFATE AUTOHALER (2 Df - 2puffs) (View Albuterol Sulfate Autohaler Review and Albuterol Sulfate Autohaler Label ), TYLOX (1 Df - 5/325mg) (View Tylox Review and Tylox Label ). Patient was hospitalized.

6942342-1 | Dehydration, Failure To Thrive
on Aug 23, 2010 Male patient from UNITED STATES , 54 years of age, weighting 233.7 lb, was diagnosed with non-small cell lung cancer and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, failure to thrive. Paclitaxel dosage: Total Dose 456 Mg.cycle 3. During the same period patient was treated with CARBOPLATIN (1 Dosage Form=6auc(total Daily Dose Of1100.4mg). Cycles 3) (View Carboplatin Review and Carboplatin Label ), CP 751,871 (Total Dose 1061mg.) (View Cp-751,871 Review and Cp-751,871 Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CODEINE + GUAIFENESIN (View Codeine + Guaifenesin Review and Codeine + Guaifenesin Label ), ULTRAM (View Ultram Review and Ultram Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), AMBIEN (View Ambien Review and Ambien Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6939629-5 | Arthralgia, Dyspnoea, Face Oedema, Localised Oedema, Microstomia, Motor Dysfunction, Neuralgia
Patient was taking Paclitaxel (View Usage). Patient had the following side effects: arthralgia, dyspnoea, face oedema, localised oedema, microstomia, motor dysfunction, neuralgia on Aug 11, 2010 from DENMARK Additional patient health information: Female patient , 52 years of age, was diagnosed with malignant peritoneal neoplasm, ovarian cancer and. Paclitaxel dosage: 305 Mg Milligrarm(s) , Intravenous. During the same period patient was treated with FENTANYL CITRATE (View Fentanyl Citrate Review and Fentanyl Citrate Label ), ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), THIOPENTAL SODIUM (View Thiopental Sodium Review and Thiopental Sodium Label ), PROPOFOL (View Propofol Review and Propofol Label ), ALFENTANIL (View Alfentanil Review and Alfentanil Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6939480-6 | Acute Respiratory Distress Syndrome, Cardiopulmonary Failure, Interstitial Lung Disease, Po2 Decreased, Respiratory Failure
Adverse event was reported on Aug 11, 2010 by a Male patient taking Paclitaxel (View Usage) (Dosage: ) was diagnosed with angina pectoris and. Location: JAPAN , 74 years of age, After Paclitaxel was administered, patient had the following side effects: acute respiratory distress syndrome, cardiopulmonary failure, interstitial lung disease, po2 decreased, respiratory failure. During the same period patient was treated with CON MEDS (View Con Meds Review and Con Meds Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized.

6937776-5 | Bone Marrow Failure, Recall Phenomenon
on Aug 18, 2010 Female patient from FRANCE , 74 years of age, was diagnosed with breast cancer in situ and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, recall phenomenon. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), TRASTUZUMAB (View Trastuzumab Review and Trastuzumab Label ).

6933533-4 | Cerebral Haemorrhage, Cystitis, Malignant Neoplasm Progression, Thrombocytopenia
on Aug 18, 2010 Female patient from UNITED STATES , 69 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer, neutropenia, cystitis, nausea (What is nausea?), herpes simplex (What is herpes simplex?) and was treated with Paclitaxel (View Usage). Patient had the following side effects: cerebral haemorrhage, cystitis, malignant neoplasm progression, thrombocytopenia. Paclitaxel dosage: 1st Cycle: 12may 2nd Cycle: 08jun2010. During the same period patient was treated with CARBOPLATIN (1 Df = Auc 6mg/ml/mint;cyc 1: 417mg 1 In 21d;cyc 2: 324mg ,1 In 21 D From 08jun10;) (View Carboplatin Review and Carboplatin Label ), PEGFILGRASTIM (View Pegfilgrastim Review and Pegfilgrastim Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), PHENERGAN (View Phenergan Review and Phenergan Label ), ACYCLOVIR (Total Dose 800 Mg (400 Mg, 2 In 1 D)) (View Acyclovir Review and Acyclovir Label ), MIRACLE MOUTHWASH (View Miracle Mouthwash Review and Miracle Mouthwash Label ), PAMIDRONATE DISODIUM (View Pamidronate Disodium Review and Pamidronate Disodium Label ). Patient was hospitalized.

6933495-X | Dehydration, Febrile Neutropenia, Pyrexia
Patient was taking Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: dehydration, febrile neutropenia, pyrexia on Aug 18, 2010 from UNITED STATES Additional patient health information: Female patient , 71 years of age, was diagnosed with lung cancer metastatic, gastrooesophageal reflux disease, asthma (What is asthma?), vitamin supplementation and. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (1 Dosage Form = 6mg/ml/min) (View Carboplatin Review and Carboplatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SALBUTAMOL SULFATE (View Salbutamol Sulfate Review and Salbutamol Sulfate Label ), VIGRAN (View Vigran Review and Vigran Label ), CYANOCOBALAMIN ZINC TANNATE COMPLEX (View Cyanocobalamin-zinc Tannate Complex Review and Cyanocobalamin-zinc Tannate Complex Label ), CHROMIUM PICOLINATE (View Chromium Picolinate Review and Chromium Picolinate Label ). Patient was hospitalized.

6927703-9 | Anxiety, Flushing, Hypotension, Wheezing
Adverse event was reported on Aug 16, 2010 by a Female patient taking Paclitaxel (View Usage) (Dosage: 76mg In 250 Normal Saline At 10ml/hr Other Iv) was diagnosed with non-small cell lung cancer stage iii and. Location: UNITED STATES , 43 years of age, weighting 114.6 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), flushing, hypotension, wheezing.

6927403-5 | Flushing, Hypertension, Loss Of Consciousness
on Aug 13, 2010 Female patient from UNITED KINGDOM , 51 years of age, weighting 165.3 lb, was diagnosed with breast cancer recurrent and was treated with Paclitaxel (View Usage). Patient had the following side effects: flushing, hypertension, loss of consciousness. Paclitaxel dosage: .

6925254-9 | Confusional State
on Aug 12, 2010 Female patient from UNITED KINGDOM , 77 years of age, weighting 132.3 lb, was diagnosed with ovarian cancer and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: confusional state. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (1df-auc 6) (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6920208-0 | Hypoaesthesia, Neuropathy Peripheral, Paraesthesia, Viith Nerve Paralysis
Patient was taking Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia, neuropathy peripheral, paraesthesia, viith nerve paralysis on Jul 20, 2010 from IRAN (ISLAMIC REPUBLIC OF) Additional patient health information: Female patient , 56 years of age, was diagnosed with ovarian epithelial cancer stage iii and. Paclitaxel dosage: (175 Mg/m2,over 6-8 Hours: Repeated Every 3 Weeks). During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6919836-8 | Dyspnoea, Hypoxia, Radiation Associated Pain, Radiation Oesophagitis
Adverse event was reported on Aug 10, 2010 by a Male patient taking Paclitaxel (View Usage) (Dosage: 81 Mg Weekly X 7 Iv) was diagnosed with lung neoplasm malignant and. Location: UNITED STATES , weighting 168.4 lb, Patient had the following side effects: dyspnoea, hypoxia, radiation associated pain, radiation oesophagitis. During the same period patient was treated with CARBOPLATIN (221 Mg Weekly X 7 Iv) (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6918103-6 | Back Pain, Flushing
on Jul 28, 2010 Male patient from SPAIN , 55 years of age, was diagnosed with metastatic neoplasm and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: back pain (What is back pain?), flushing. Paclitaxel dosage: 300 Mg Milligram(s), Intravenous. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), DEXCHLORPHENIRAMINE MALEATE (View Dexchlorpheniramine Maleate Review and Dexchlorpheniramine Maleate Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

6916506-7 | Cerebral Haemorrhage, Cystitis, Malignant Neoplasm Progression, Thrombocytopenia
on Aug 05, 2010 Female patient from UNITED STATES , 69 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer, neutropenia, cystitis, nausea (What is nausea?), herpes simplex (What is herpes simplex?) and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, cystitis, malignant neoplasm progression, thrombocytopenia. Paclitaxel dosage: 1st Cycle: 12may 2nd Cycle: 08jun2010. During the same period patient was treated with CARBOPLATIN (1 Df = Auc 6mg/ml/mint;cyc 1: 417mg 1 In 21d;cyc 2: 324mg ,1 In 21 D From 08jun10;) (View Carboplatin Review and Carboplatin Label ), PEGFILGRASTIM (View Pegfilgrastim Review and Pegfilgrastim Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), PHENERGAN (View Phenergan Review and Phenergan Label ), ACYCLOVIR (Total Dose 800 Mg (400 Mg, 2 In 1 D)) (View Acyclovir Review and Acyclovir Label ), MIRACLE MOUTHWASH (View Miracle Mouthwash Review and Miracle Mouthwash Label ), PAMIDRONATE DISODIUM (View Pamidronate Disodium Review and Pamidronate Disodium Label ). Patient was hospitalized.

6914086-3 | Scleroderma
Patient was taking Paclitaxel (View Usage). Patient had the following side effects: scleroderma (What is scleroderma?) on Aug 04, 2010 from JAPAN Additional patient health information: Female patient , 67 years of age, was diagnosed with ovarian cancer and. Paclitaxel dosage: 1df: 175mg/m Sup(2)(90% Of Paclitaxel = 210 Mg/body)5th Course Withdrawn. During the same period patient was treated with CARBOPLATIN (1df: 500mg/body,auc 5 Also Recieves On 20-nov-2007,600mg/body.5th Course Withdrawn) (View Carboplatin Review and Carboplatin Label ).

6913330-6 | Dehydration, Ileus, Pneumonia Aspiration
Adverse event was reported on Jul 30, 2010 by a Female patient taking Paclitaxel (View Usage) (Dosage: 80 Mg/m^2, On 16-jun-2010, 23-jun-2010, 30-jun-2010) was diagnosed with breast cancer (What is breast cancer?), hyperlipidaemia, diarrhoea, gastritis prophylaxis, cancer pain, hypertension and. Location: JAPAN , weighting 152.1 lb, After Paclitaxel was administered, patient had the following side effects: dehydration, ileus, pneumonia aspiration. During the same period patient was treated with OLANZAPINE (Dose Not Provided) (View Olanzapine Review and Olanzapine Label ), SIMVASTATIN (Dose Not Provided) (View Simvastatin Review and Simvastatin Label ), LOPERAMIDE (Dose Not Provided) (View Loperamide Review and Loperamide Label ), LAFUTIDINE (Dose Not Provided) (View Lafutidine Review and Lafutidine Label ), LOXOPROFEN SODIUM (Dose Not Provided) (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ), NIFEDIPINE (Dose Not Provided) (View Nifedipine Review and Nifedipine Label ), CILOSTAZOL (Dose Not Provided) (View Cilostazol Review and Cilostazol Label ). Patient was hospitalized.

6907335-9 | Cyanosis, Dyspnoea, Hyperhidrosis, Sensation Of Foreign Body
on Jul 20, 2010 Male patient from ITALY , 58 years of age, was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: cyanosis, dyspnoea, hyperhidrosis, sensation of foreign body. Paclitaxel dosage: 150 Mg Milligram(s), Intravenous. During the same period patient was treated with (PLASIL /00041901/) (View (plasil /00041901/) Review and (plasil /00041901/) Label ), (RANIDIL) (View (ranidil) Review and (ranidil) Label ), (SOLDESAM .00016002/) (View (soldesam .00016002/) Review and (soldesam .00016002/) Label ), (TRIMETON /00072502/) (View (trimeton /00072502/) Review and (trimeton /00072502/) Label ).

6906260-7 | Neuropathy Peripheral, Viith Nerve Paralysis
on Jul 27, 2010 Female patient from JAPAN , 56 years of age, was diagnosed with ovarian epithelial cancer stage iii and was treated with Paclitaxel (View Usage). Patient had the following side effects: neuropathy peripheral, viith nerve paralysis. Paclitaxel dosage: 175 Mg/bsa Over 6-8 Hour.. During the same period patient was treated with CARBOPLATIN (1 Df=6 Auc.) (View Carboplatin Review and Carboplatin Label ).

6895462-4 | Blood Potassium Decreased, Candidiasis, Constipation, Failure To Thrive, Fluid Intake Reduced, Haematocrit Decreased, Haemoglobin Decreased, Heart Rate Increased, Hypophagia
Patient was taking Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: blood potassium decreased, candidiasis, constipation (What is constipation?), failure to thrive, fluid intake reduced, haematocrit decreased, haemoglobin decreased, heart rate increased, hypophagia on Jul 28, 2010 from UNITED STATES Additional patient health information: Male patient , 64 years of age, weighting 112.4 lb, was diagnosed with non-small cell lung cancer, insomnia, constipation (What is constipation?), hypercholesterolaemia, dyspnoea, cough, pain (What is pain?) and. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), DOCUSATE SODIUM (1 Df - 100-200mg) (View Docusate Sodium Review and Docusate Sodium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), SALBUTAMOL (2 Df - 2puffs) (View Salbutamol Review and Salbutamol Label ), TYLOX (1 Df - 5/325mg) (View Tylox Review and Tylox Label ). Patient was hospitalized.

6883585-5 | Anaphylactic Shock
Adverse event was reported on Jul 23, 2010 by a Male patient taking Paclitaxel (View Usage) (Dosage: ) was diagnosed with malignant melanoma and. Location: SWEDEN , 39 years of age, Patient experienced the following unwanted or unexpected effects: anaphylactic shock. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), PRIMPERAN TAB (View Primperan Tab Review and Primperan Tab Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), BETAPRED (View Betapred Review and Betapred Label ), TAVEGYL (View Tavegyl Review and Tavegyl Label ), DACARBAZINE (View Dacarbazine Review and Dacarbazine Label ).

6859669-4 | Amnesia, Cognitive Disorder, Confusional State, Disorientation
on Jul 16, 2010 Female patient from UNITED KINGDOM , 77 years of age, weighting 132.3 lb, was diagnosed with ovarian cancer and was treated with Paclitaxel (View Usage). Patient had the following side effects: amnesia, cognitive disorder, confusional state, disorientation. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (1df-auc 6) (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6844748-8 | Cerebral Haemorrhage, Thrombocytopenia
on Jul 13, 2010 Female patient from UNITED STATES , 69 years of age, weighting 138.9 lb, was diagnosed with non-small cell lung cancer, neutropenia, cystitis, nausea (What is nausea?), herpes simplex (What is herpes simplex?) and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: cerebral haemorrhage, thrombocytopenia. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (1 Df = Auc 6mg/ml/mint) (View Carboplatin Review and Carboplatin Label ), PEGFILGRASTIM (View Pegfilgrastim Review and Pegfilgrastim Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), PHENERGAN (View Phenergan Review and Phenergan Label ), ACYCLOVIR (Total Dose 800 Mg (400 Mg, 2 In 1 D)) (View Acyclovir Review and Acyclovir Label ), MIRACLE MOUTHWASH (View Miracle Mouthwash Review and Miracle Mouthwash Label ), PAMIDRONATE DISODIUM (View Pamidronate Disodium Review and Pamidronate Disodium Label ). Patient was hospitalized.

6843523-8 | Cyanosis, Dyspnoea, Hyperhidrosis, Sensation Of Foreign Body
Patient was taking Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: cyanosis, dyspnoea, hyperhidrosis, sensation of foreign body on Jun 28, 2010 from ITALY Additional patient health information: Male patient , 58 years of age, . Paclitaxel dosage: 150 Mg Milligram(s), Intravenous. During the same period patient was treated with (SOLDESAM /00016002/) (View (soldesam /00016002/) Review and (soldesam /00016002/) Label ), (TRIMETON /00072502/) (View (trimeton /00072502/) Review and (trimeton /00072502/) Label ), (RANIDIL) (View (ranidil) Review and (ranidil) Label ), (PLASIL /00041901/) (View (plasil /00041901/) Review and (plasil /00041901/) Label ).

6840429-5 | Acute Myeloid Leukaemia, Pancytopenia
Adverse event was reported on Jul 09, 2010 by a Female patient taking Paclitaxel (View Usage) (Dosage: ) was diagnosed with ovarian cancer and. Location: JAPAN , 48 years of age, Patient had the following side effects: acute myeloid leukaemia, pancytopenia. During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

6840370-8 | Failure To Thrive, Pneumonia, Pneumothorax
on Jul 13, 2010 Male patient from UNITED STATES , 64 years of age, weighting 112.4 lb, was diagnosed with non-small cell lung cancer, insomnia, constipation (What is constipation?), hypercholesterolaemia, dyspnoea, cough, pain (What is pain?) and was treated with Paclitaxel (View Usage). After Paclitaxel was administered, patient had the following side effects: failure to thrive, pneumonia (What is pneumonia?), pneumothorax. Paclitaxel dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), DOCUSATE SODIUM (1 Df - 100-200mg) (View Docusate Sodium Review and Docusate Sodium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), SALBUTAMOL (2 Df - 2puffs) (View Salbutamol Review and Salbutamol Label ), TYLOX (1 Df - 5/325mg) (View Tylox Review and Tylox Label ). Patient was hospitalized.

6839154-6 | Dehydration, Pneumonia
on Jul 08, 2010 Female patient from JAPAN , weighting 152.1 lb, was diagnosed with breast cancer (What is breast cancer?), hyperlipidaemia, diarrhoea, gastritis prophylaxis, hypertension and was treated with Paclitaxel (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, pneumonia (What is pneumonia?). Paclitaxel dosage: 80 Mg/m^2, Frequency Not Provided. During the same period patient was treated with OLANZAPINE (Dose Not Provided) (View Olanzapine Review and Olanzapine Label ), SIMVASTATIN (Dose Not Provided) (View Simvastatin Review and Simvastatin Label ), LOPERAMIDE (Dose Not Provided) (View Loperamide Review and Loperamide Label ), LAFUTIDINE (Dose Not Provided) (View Lafutidine Review and Lafutidine Label ), LOXOPROFEN SODIUM (Dose Not Provided) (View Loxoprofen Sodium Review and Loxoprofen Sodium Label ), NIFEDIPINE (Dose Not Provided) (View Nifedipine Review and Nifedipine Label ), CILOSTAZOL (Dose Not Provided) (View Cilostazol Review and Cilostazol Label ), TRASTUZUMAB (^4 Mg/kg To 2 Mg/kg^, Frequency Not Provided) (View Trastuzumab Review and Trastuzumab Label ). Patient was hospitalized.

6821698-4 | Bradycardia, Confusional State, Hypersensitivity, Hypotension, Hypoxia, Nausea, Respiratory Arrest
Patient was taking Paclitaxel (View Usage). Patient had the following side effects: bradycardia, confusional state, hypersensitivity, hypotension, hypoxia, nausea (What is nausea?), respiratory arrest on Jun 28, 2010 from AUSTRALIA Additional patient health information: Female patient , 65 years of age, weighting 154.3 lb, was diagnosed with ovarian cancer and. Paclitaxel dosage: 312 Mg Milligram(s), Intravenous;312 Mg Milligram(s). During the same period patient was treated with CARBOPLATIN (590 Mg Milligram(s), Intravenous; 590 Mg Milligram(s)) (View Carboplatin Review and Carboplatin Label ), GRANISETRON HCL (View Granisetron Hcl Review and Granisetron Hcl Label ), DEXAMETHASONE ACETATE (View Dexamethasone Acetate Review and Dexamethasone Acetate Label ). Patient was hospitalized.